← Leaderboards
Laura Elizabeth Fredenburgh
Brigham And Women'S Hospital
$4,191,382
Attributed
$5,403,285
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2008–20$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$5,403,285 · 5
By mechanism
R01$4,024,229 · 2
K08$751,895 · 1
R61$452,945 · 1
R03$174,216 · 1
Top collaborators
- Daniel J. Tschumperlin4 shared
- Augustine M Choi1 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Bradley Wertheim$1,908,343
- Bradley Maron$8,442,424
- Rebecca M Baron$10,418,078
- Georgios Triantafyllou$170,538
- Mark A Perrella$18,447,731
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsHemodynamicsHypoxiaLungCessation Of LifeResponseProstaglandinsMediator Of Activation ProteinInflammationLeadCyclooxygenase 2ResolutionMortality Vital StatisticsPlayProstaglandin-Endoperoxide SynthaseStimulusProgramsPathway InteractionsMechanicsPathogenesisHeart FailureBmpr2 GeneFeedbackHeart
Grant awards (18)
Mechanotransduction and YAP/TAZ Signaling in Pulmonary Arterial Hypertension$633,187
R01 · FY2020 · HL · contact PI
A Phase 1b Study of Inhaled CO for the Treatment of Sepsis-Induced ARDS$452,945
R61 · FY2020 · HL
Mechanotransduction and YAP/TAZ Signaling in Pulmonary Arterial Hypertension$33,237
R01 · FY2020 · HL · contact PI
Mechanotransduction and YAP/TAZ Signaling in Pulmonary Arterial Hypertension$634,572
R01 · FY2019 · HL · contact PI
Mechanotransduction and YAP/TAZ Signaling in Pulmonary Arterial Hypertension$669,866
R01 · FY2018 · HL · contact PI
Mechanobiology of Vascular Remodeling in Pulmonary Arterial Hypertension$417,862
R01 · FY2016 · HL · contact PI
Mechanobiology of Vascular Remodeling in Pulmonary Arterial Hypertension$412,991
R01 · FY2015 · HL · contact PI
Mechanobiology of Vascular Remodeling in Pulmonary Arterial Hypertension$400,705
R01 · FY2014 · HL · contact PI
Mechanobiology of Vascular Remodeling in Pulmonary Arterial Hypertension$390,531
R01 · FY2013 · HL · contact PI
Arterial Stiffness in the Pathogenesis of Human Pulmonary Arterial Hypertension$84,966
R03 · FY2013 · HL · contact PI
Mechanobiology of Vascular Remodeling in Pulmonary Arterial Hypertension$431,278
R01 · FY2012 · HL · contact PI
Role of Cyclooxygenase-2-derived Prostanoids in Polymicrobial Sepsis$120,095
K08 · FY2012 · GM · contact PI
Arterial Stiffness in the Pathogenesis of Human Pulmonary Arterial Hypertension$89,250
R03 · FY2012 · HL · contact PI
Role of Cyclooxygenase-2-derived Prostanoids in Polymicrobial Sepsis$130,950
K08 · FY2011 · GM · contact PI
Role of Cyclooxygenase-2-derived Prostanoids in Polymicrobial Sepsis$130,950
K08 · FY2010 · GM · contact PI
Role of Cyclooxygenase-2-derived Prostanoids in Polymicrobial Sepsis$130,950
K08 · FY2009 · GM · contact PI
Role of Cyclooxygenase-2-derived Prostanoids in Polymicrobial Sepsis$108,000
K08 · FY2009 · GM · contact PI
Role of Cyclooxygenase-2-derived Prostanoids in Polymicrobial Sepsis$130,950
K08 · FY2008 · GM · contact PI